<DOC>
	<DOCNO>NCT01196923</DOCNO>
	<brief_summary>The purpose study confirm safety effectiveness CardioFocus Endoscopic Ablation System Adaptive Contact treatment atrial fibrillation .</brief_summary>
	<brief_title>Post-Market Clinical Study CardioFocus Endoscopic Ablation System - Adaptive Contact ( CF-EAS-AC ) Treatment Symptomatic Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Symptomatic , Paroxysmal Atrial Fibrillation ( AF ) 18 70 Years age Others Generally good overall health determine multiple criterion Willing participate study Others</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>